MIKEL
GARCÍA PUGA
![Foto de MIKEL](/img/nophoto.png)
![Foto de Ikerbasque, Fundación Vasca para la Ciencia](/img/noimage_org.png)
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicaciones en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (8)
2022
-
Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity
Cancer Research, Vol. 82, Núm. 7, pp. 1283-1297
-
Targeting Myotonic Dystrophy Type 1 with Metformin
International Journal of Molecular Sciences, Vol. 23, Núm. 5
2020
-
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
Aging, Vol. 12, Núm. 7, pp. 6260-6275
-
SOX9 promotes tumor progression through the axis BMI1-p21CIP
Scientific Reports, Vol. 10, Núm. 1
2019
-
Therapeutic relevance of SOX9 stem cell factor in gastric cancer
Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 2, pp. 143-152
2018
-
Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer
Therapeutic Advances in Medical Oncology, Vol. 10
2016
-
Paradoxical role of SOX2 in gastric cancer
American Journal of Cancer Research, Vol. 6, Núm. 4, pp. 701-713
-
SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression
Cancer Research, Vol. 76, Núm. 22, pp. 6735-6746